Abstract：Objective: To study Curative efficacy of Vidarabine monophosphate combined with primeresch in treatment of Children with bronchiolitis and its effectson serum Leukotriene E4 (LTE4), monocyte chemokinin-1 (McP-1), interferon-gamma (inf-gamma). Methods: 90 children with bronchiolitis treated in our hospital from February 2015 to February 2017 was conducted, they were randomly divided into observation group (n=48) and control group (n=42). The observation group was treated with adenosine monophosphate combined with pulmicort respules. The control group was treated with pulmicort respules. The clinical efficacy, serum LTE4, McP-1, inf-gamma, TNF- alpha, interleukin-6 (il-6), interleukin-8 (il-8), time of disappearance of clinical symptoms and adverse reactions in the two groups were compared. Results: The effective rate of the observation group was 95.83%, significantly higher than that of the control group (80.95%, P<0.05). After treatment, serum LTE4, McP-1 and inf-gamma levels were significantly improved in the two groups (P<0.05). Serum LTE4 and McP-1 levels in the observation group were lower than those in the control group, and inf-gamma levels were significantly higher than those in the control group (P<0.05). After treatment, serum tnf-alpha, il-6 and il-8 levels were significantly improved in both groups (P<0.05). Serum tnf-alpha, il-6 and il-8 levels in the observation group were lower than those in the control group (P<0.05). The time of antipyretic, time of disappearance of moist rale, time of disappearance of wheezing, time of disappearance of cough and time of hospitalization in the observation group was significantly lower than that in the control group (P<0.05). The total incidence of rash, nausea, diarrhea and angioedema in the two groups was 8.33% and 16.67%, respectively, with no statistically significant difference (P>0.05). Conclusion: The efficacy of adenosine monophosphate combined with pramikacin in the treatment of bronchiolitis in children is relatively high, which can effectively improve the serum LTE4, McP-1 and inf-gamma levels in patients with less adverse reactions, and the children are basically tolerable and worthy of popularization and application.
晁玉瑾. 单磷酸阿糖腺苷联合普米克令舒对毛细支气管炎患儿的疗效及对血清LTE4 MCP-1 INF-γ的影响[J]. 河北医学, 2019, 25(8): 1280-1283.
CHAO Yujin. Effects of Adenosine Monophosphate combined with Pulmicort Respules on Serum LTE4, MCP-1 and INF-gamma in Children with Bronchiolitis. HeBei Med, 2019, 25(8): 1280-1283.
[1] 陈娜,韩洁.喘可治注射液雾化吸入对婴幼儿毛细支气管炎的疗效及对肺功能的影响[J].中药材,2015,38(5):1099~1102. [2] 侯秀玲,王敬敏,李桂娥,等.京南保北地区毛细支气管炎流行病学及病原学调查分析[J].儿科药学杂志,2015,21(11):12~15. [3] Alansari K,Sayyed R, Davidson B L, et al. Intravenous magnesium sulfate for bronchiolitis: A randomized trial.[J]. Chest, 2017, 97(2):113~119. [4] 王亚亭.毛细支气管炎的诊断、治疗和预防[J].实用儿科临床杂志,2008,22(10):801~804. [5] Williams K M, Cheng G S, Pusic I, et al. Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation[J]. Biology of Blood & Marrow Transplantation, 2016, 22(4):710~716. [6] 赵茜叶,周旭华,于艳艳,等.呼吸道合胞病毒毛细支气管炎患儿Th17细胞亚群的变化[J].临床儿科杂志,2014,32(2):193. [7] 张秀秀,曲书强.毛细支气管炎患儿外周血中IL-17和IL-23水平变化及意义[J].中国儿童保健杂志,2014,22(1):65~67. [8] Freeman HJ, Davis JE, Prest ME, et al. Granulomatous bronchiolitis with necrobiotic pulmonary nodules in Crohn's disease[J]. Canadian Journal of Gastroenterology,2016, 18(11):687~690. [9] Jr H D, Black S M, Tobias J D, et al. Influence of human leukocyte antigen mismatching on bronchiolitis obliterans syndrome in lung transplantation[J]. Journal of Heart & Lung Transplantation the Official Publication of the International Society for Heart Transplantation, 2016, 35(2):186~194. [10] 隋登宇.单磷酸阿糖腺苷联合布地奈德治疗小儿毛细支气管炎的临床研究[J].现代药物与临床,2017,32(2):241~244. [11] Piipposavolainen E, Remes S, Kannisto S, et al. Early predictors for adult asthma and lung function abnormalities in infants hospitalized for bronchiolitis: a prospective 18- to 20-year follow-up.[J]. Allergy & Asthma Proceedings, 2016, 27(4):341~349. [12] 沈杨,罗菲菲,王亚亭,等.孟鲁司特钠联合维生素D辅助治疗呼吸道合胞病毒毛细支气管炎的疗效观察[J].安徽医科大学学报,2018,53(2):297~300.
2019, Vol. 25 
冀公网安备13080202000677号